Pneumonia Studies Confirm Value of Batch Treatment
FRANCE - Apparently healthy cattle that are in-contact with pen mates showing signs of pneumonia gain significantly less weight and take longer to finish than animals in completely disease-free housing.

Lower Volume, Easier to Administer Pneumonia Treatment
GENERAL - Intervet/Schering-Plough Animal Health has launched a lower volume, easier-to-administer Nuflor formulation licensed for the treatment and prevention of bacterial pneumonia.

New Intranasal Vaccine Protects Young Calves
US - Intervet/Schering-Plough Animal Health, Millsboro, Del., recently announced the availability of Onset 5 IN, the first intranasally administered, five-way modified-live virus (MLV) vaccine for healthy cattle 3 to 8 days and older.

Bluetongue Protection Zone Keeps Expanding
UK - Defra has today announced that the Bluetongue Protection Zone will be extended again on Monday 14 July, following the delivery by Intervet of over 2 million additional doses of Bluetongue vaccine.

Intervet/Schering-Plough Animal Health appoints Executive Team
THE NETHERLANDS – Schering-Plough appointed the Executive Team members of the company’s global animal health unit: Intervet / Schering- Plough Animal Health. These appointments define the major steps in the design process of the animal health unit. The...

Bluetongue Vaccine Release Outlines Strength of Intervet/SPAH Combination
NETHERLANDS - Intervet/Schering-Plough Animal Health has released the first batch of Bovilis BTV8 vaccine against bluetongue to supply in Northern Europe.

Vaccination Roll Out Plan Rolls On
UK - The JAB campaign for mass vaccination against bluetongue can step up a gear after Intervet announced its vaccine has been licensed for use in the UK. The news comes as Defra published its roll out plan and guidance notes for livestock keepers and...

Intervet to Supply France With Minimum of 27 Million Doses of Bluetongue Vaccine
FRANCE - Intervet is working intensively to supply the Bovilis BTV 8 vaccine to France as soon as possible, to support the French government and farming sector in its fight against this devastating disease.

Schering-Plough Launch Pour-On Insecticide
US - Schering-Plough Animal Health Corporation today announced the release of ULTRA SABER, a new pour-on insecticide that controls horn flies on beef cattle and calves. ULTRA SABER is a new type of pour-on insecticide that contains 1 percent lambdacyhalothrin...

Intervet Has Developed Bluetongue Vaccine
THE NETHERLANDS – Animal health company Intervet International bv, part of Schering-Plough Corporation, has developed a vaccine against Bluetongue serotype 8, for sheep and cattle. The vaccine has been taken into production now. Intervet is aiming to...

Defra Orders a Batch of Bluetongue Vaccine
UK - The Department for Environment, Food and Rural Affairs (Defra) has today announced that it is placing a firm order with pharmaceutical company Intervet to supply 22.5 million doses of Bluetongue vaccine.

Schering-Plough Completes Acquisition of Organon BioSciences
KENILWORTH - Combination Expands Human Health Business, Creates a Global Leader in Animal Health and Strengthens Product Pipeline, Adding Five Phase III Projects

Third Quarter Results Confirm SPs Solid Position
NEW JERSEY - The finances of world-leading pharmaceutical giant Schering-Plough are very much in order. The company has recorded its 12th consecutive quarter of double-digit adjusted sales growth putting it in prime position for the integration of the...

Euro approval for the World's largest animal health business
EUROPE - Schering-Plough Corporation has received European Commission approval for its planned acquisition of Organon BioSciences, from Akzo Nobel.

Leptospirosis Presence Established In 70% Of UK Herds
UK - Around 70% of unvaccinated UK herds continue to show evidence of leptospirosis infection, according to 2006 test results released by the Bovine Leptospirosis Information & Screening Service (BLiSS)

Intervet bought by Schering-Plough
NETHERLANDS - American based company Schering-Plough has announced it is to acquire the Dutch veterinary company Intervet as part of its buy out of Organon BioSciences, the pharmaceutical division of chemical company Akzo Nobel.

Schering-Plough Cattle Business Expands
US - Schering-Plough Animal Health announced this week it is expanding its U.S. cattle operation with the creation of separate business units for beef and dairy, each with dedicated and specialized field forces, support and management teams. The new management...

Global Animal Management Named First Interim Animal Tracking Database Provider for NAIS
NEW JERSEY, US - Global Animal Management, Inc., a wholly-owned subsidiary of Schering-Plough Animal Health, announced today the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service has named the company as an interim animal...

Schering-Plough Animal Health Corporation Introduces New Neonatal Calf Diarrhea Vaccine
NEW JERSEY, US - Contemporary viruses and subunit E. coli are distinguishing features.

Schering-Plough Animal Health Corporation Announces FDA Approval of Banamine® for Use in Lactating Dairy Cattle
BANAMINE® becomes the only non-steroidal anti-inflammatory drug.